Viewing Study NCT05100056


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
Study NCT ID: NCT05100056
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2021-10-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module